According to CNBC, Jefferies raised its price target on Meta Platforms to $875 from $710, citing the popularity of Muse, while JPMorgan said the personal AI agent could be the biggest consumer AI app since ChatGPT. Oppenheimer also lifted its target on Microsoft to $570 from $515 after a meeting at the company's headquarters, citing Azure and M365 Copilot acceleration with capital discipline. Roche said its experimental obesity injection reduced body weight by 15.5% at 48 weeks in a phase 2 trial. AutoZone reported fourth-quarter comparable sales growth of 2.7%, below the 3.8% expected, while earnings per share beat and revenue missed. Citi put KeyCorp on its 30-day positive catalyst watch list ahead of third-quarter earnings and upgraded Fifth Third to buy from neutral.
Article
Jefferies Raises Meta Platforms Target to $875 as Roche Reports 15.5% Weight Loss in Trial
--・
Avertissement : ce contenu inclut des opinions de tiers. Il ne constitue pas un conseil. Binance Ai peut être utilisée, sans garantie de résultat. Consultez les CG.